Orin is the program director for the Pharmaceutical and Medical Device Development programs, based in the Sydney Pharmacy School at the University of Sydney. She is also a regulatory affairs consultant, an adjunct Associate Professor at UNSW Sydney and teaches global regulatory affairs leadership at Arizona State University, USA. She
Professor of evidence-based pharmaceutical policy, School of Pharmacy and Charles Perkins Centre, Faculty of Medicine and Health Lead, Evidence, Policy and Influence Collaborative (EPIC), Charles Perkins Centre.
Dr Barbara Mintzes is a research scientist specialising in the study of pharmaceutical policy. Her research focuses on the effects of direct-to-consumer advertising of prescription drugs and other forms of pharmaceutical promotion on the prescribing and use of medicines. She also performs systematic reviews of clinical trial evidence regarding the